These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5069937)

  • 21. [Results of treatment of chronic tuberculosis with rifampicin and ethambutol at the sanatoria run by the Railroad Health Services].
    Ropek M; Bielecki T; Mysakowska H; Sosnowski K; Raczyński R; Pizlo S; Majchrzak A
    Gruzlica; 1974 May; 42(5):393-5. PubMed ID: 4464225
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results of treatment with ethambutol and capreomycin in chronic pulmonary tuberculosis].
    Kozakow H; Potworowska M; Janowiec M; Klimkiewicz H; Niemirowski J; Pszonicka A; Pecyna-Sielewicz J; Polazek E; Rykowska Z; Frenkel A
    Gruzlica; 1969 Jul; 37(7):659-68. PubMed ID: 5350928
    [No Abstract]   [Full Text] [Related]  

  • 23. [Late results of treatment of chronic pulmonary tuberculosis with ethambutol and capreomycin].
    Polaczek E; Lachowicz E; Araszkiewicz W; Kozakow H; Kazimierczak A; Pszonicka A; Potworowska M; Janowiec M; Styszewska H; Klimkiewicz H; Grabowska R
    Gruzlica; 1973 Jul; 41(7):789-93. PubMed ID: 4125930
    [No Abstract]   [Full Text] [Related]  

  • 24. [Characteristics of metabolic disorders in chronic destructive pulmonary tuberculosis after treatment with rifampicin and ethambutol].
    Kharakter ZhZ; Pavlenko AV
    Probl Tuberk; 1976 Nov; (11):44-9. PubMed ID: 1019127
    [No Abstract]   [Full Text] [Related]  

  • 25. [The modifications induced by ethambutol in experimental chronic tuberculosis (author's transl)].
    Eskenasy A; Diaconitza G
    Acta Tuberc Pneumol Belg; 1973; 64(1):59-73. PubMed ID: 4768063
    [No Abstract]   [Full Text] [Related]  

  • 26. [Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
    Roslik SM; Iakovleva LM; Zhitnaia VI; Grushevskiĭ ES; Poluianova RP
    Probl Tuberk; 1980 Jun; (6):30-3. PubMed ID: 7393907
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immediate results of ethambutol chemotherapy of patients with disseminated chronic destructive pulmonary tuberculosis].
    Adamovich VN; Reĭderman IB
    Vrach Delo; 1973 Oct; 10():98-102. PubMed ID: 4783315
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ethambutol monotherapy in chronic drug-resistant pulmonary tuberculosis].
    Ferraro U; Briccarello L; Vercellino E
    G Ital Mal Torace; 1968; 22(4):195-201. PubMed ID: 5743001
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effectiveness of ethambutol in chronic pulmonary tuberculosis].
    Golli V; Stefanin E; Chiper P; Stefănescu I; Popescu-Crivina IM; Anghel E; Kosinski E; Daha A; Kosinski M; Floricel N
    Ftiziologia; 1972; 21(5):489-94. PubMed ID: 4632131
    [No Abstract]   [Full Text] [Related]  

  • 30. [Monotherapy with ethambutol in chronic drug-resistant tuberculosis].
    Duchi G; Mostardini G; Palatresi R
    Atti Accad Fisiocrit Siena Med Fis; 1967; 16(1):41-58. PubMed ID: 5621900
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of chronic pulmonary tuberculosis with rifampin and ethambutol by the continuous and intermittent methods].
    Kotowska M; Zelski S
    Gruzlica; 1974 May; 42(5):417-9. PubMed ID: 4464230
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immediate results of strictly supervised, intermittent treatment with rifampicin and ethambutol in patients with chronic pulmonary tuberculosis].
    Josefovics F; Vojth B; Vojth V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(1):35-8. PubMed ID: 191889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative characteristics of the use of rifadin and ethambutol in the complex treatment of patients with fibro-cavernous pulmonary tuberculosis].
    Tarasova EF; Sagalovich VIa
    Probl Tuberk; 1974; (12):26-30. PubMed ID: 4445131
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of chronic tuberculosis patients with ethambutol and protoionamide combined with rifampicin and capreomicin].
    Grassi C; Cornia G; Cirianni C; Garimoldi M; Ginesu F; Mandler F; Perna G; Pradella F
    G Ital Chemioter; 1968; 15(4):92-4. PubMed ID: 5744843
    [No Abstract]   [Full Text] [Related]  

  • 35. [Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].
    Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Oussedik N; Coucke C; Benabdallah L
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):559-66. PubMed ID: 4928583
    [No Abstract]   [Full Text] [Related]  

  • 36. [Personal first experiences with ethambutol].
    Dosen D; Kotrosan R; Bojanić-Seskar B
    Plucne Bolesti Tuberk; 1970; 22(3):257-9. PubMed ID: 5206696
    [No Abstract]   [Full Text] [Related]  

  • 37. [Rifampicin, ethambutol and drugs of the 2d series in chemotherapy of chronic cavernous tuberculosis of the lungs].
    Mamolat AS; Bialik IB
    Probl Tuberk; 1979 Nov; (11):20-6. PubMed ID: 530963
    [No Abstract]   [Full Text] [Related]  

  • 38. [Contribution to the study of the antimycobacterial activity of ethambutel in chronic pulmonary tuberculosis].
    Ramacciotti PG; Lijoi N; Busin M
    G Ital Mal Torace; 1967; 21(4):197-200. PubMed ID: 4970414
    [No Abstract]   [Full Text] [Related]  

  • 39. [Early results of treatment of chronic pulmonary tuberculosis with rifampicin and ethambutol adminstered intermittently once or twice a week preceded by a 3-month continuous administration].
    Kost A; Moskwa Z
    Gruzlica; 1975 Aug; 43(8):719-26. PubMed ID: 1158177
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experience with long-term application of ethambutol in ambulatory and hospitalized patients with chronic destructive tuberculosis of the lungs].
    Rudoi NM; Eisaev BA
    Probl Tuberk; 1973; 51(1):42-6. PubMed ID: 4199376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.